Sign In

Login

Password

Forgot Password ? Sign Up

Temozolomida (Spanish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Temozolomida" in Spanish language version.

refsWebsite
Global rank Spanish rank
8doi.org
2nd place
2nd place
8nih.gov
4th place
4th place
2europa.eu
68th place
91st place
1nice.org.uk
3,258th place
2,987th place
1unil.ch
9,112th place
low place
1semanticscholar.org
11th place
79th place
1sciencemag.org
857th place
313th place

doi.org

dx.doi.org

  • Sasmita AO, Wong YP, Ling AP (February 2018). «Biomarkers and therapeutic advances in glioblastoma multiforme». Asia-Pacific Journal of Clinical Oncology 14 (1): 40-51. PMID 28840962. doi:10.1111/ajco.12756. 
  • Farago AF, Yeap BY, Stanzione M, Hung YP, Heist RS, Marcoux JP, Zhong J, Rangachari D, Barbie DA, Phat S, Myers DT, Morris R, Kem M, Dubash TD, Kennedy EA, Digumarthy SR, Sequist LV, Hata AN, Maheswaran S, Haber DA, Lawrence MS, Shaw AT, Mino-Kenudson M, Dyson NJ, Drapkin BJ (October 2019). «Combination Olaparib and Temozolomide in Relapsed Small-Cell Lung Cancer». Cancer Discov 9 (10): 1372-1387. PMC 7319046. PMID 31416802. doi:10.1158/2159-8290.CD-19-0582. 
  • «Chimiothérapie à gonadotoxicité inconnue et préservation de la fertilité: Exemple du témozolomide» [Unknown gonadotoxicity chemotherapy and preservation of fertility: example of Temozolomide]. Gynécologie, Obstétrique & Fertilité (en francés) 38 (11): 660-2. November 2010. PMID 21030284. doi:10.1016/j.gyobfe.2010.09.002.  Parámetro desconocido |vauthors= ignorado (ayuda)
  • Jacinto FV, Esteller M (August 2007). «MGMT hypermethylation: a prognostic foe, a predictive friend». DNA Repair 6 (8): 1155-60. PMID 17482895. doi:10.1016/j.dnarep.2007.03.013. 
  • Hegi ME, Diserens AC, Gorlia T, Hamou MF, de Tribolet N, Weller M, Kros JM, Hainfellner JA, Mason W, Mariani L, Bromberg JE, Hau P, Mirimanoff RO, Cairncross JG, Janzer RC, Stupp R (March 2005). «MGMT gene silencing and benefit from temozolomide in glioblastoma». The New England Journal of Medicine 352 (10): 997-1003. PMID 15758010. doi:10.1056/NEJMoa043331. 
  • Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, Ludwin SK, Allgeier A, Fisher B, Belanger K, Hau P, Brandes AA, Gijtenbeek J, Marosi C, Vecht CJ, Mokhtari K, Wesseling P, Villa S, Eisenhauer E, Gorlia T, Weller M, Lacombe D, Cairncross JG, Mirimanoff RO, ((European Organisation for Research Treatment of Cancer Brain Tumour Radiation Oncology Groups)), ((National Cancer Institute of Canada Clinical Trials Group))) (May 2009). «Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial». The Lancet. Oncology 10 (5): 459-66. PMID 19269895. doi:10.1016/S1470-2045(09)70025-7. 
  • Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, Ludwin SK, Allgeier A, Fisher B, Belanger K, Hau P, Brandes AA, Gijtenbeek J, Marosi C, Vecht CJ, Mokhtari K, Wesseling P, Villa S, Eisenhauer E, Gorlia T, Weller M, Lacombe D, Cairncross JG, Mirimanoff RO, ((European Organisation for Research Treatment of Cancer Brain Tumour Radiation Oncology Groups)), ((National Cancer Institute of Canada Clinical Trials Group))) (May 2009). «Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial». The Lancet. Oncology 10 (5): 459-66. PMID 19269895. doi:10.1016/S1470-2045(09)70025-7. 
  • Sperry, Jeffrey B.; Stone, Shane; Azuma, Michael; Barrett, Connor (2021). «Importance of Thermal Stability Data to Avoid Dangerous Reagents: Temozolomide Case Study». Organic Process Research & Development 25 (7): 1690-1700. S2CID 237644612. doi:10.1021/acs.oprd.1c00206. 

europa.eu

ema.europa.eu

nice.org.uk

nih.gov

ncbi.nlm.nih.gov

  • Sasmita AO, Wong YP, Ling AP (February 2018). «Biomarkers and therapeutic advances in glioblastoma multiforme». Asia-Pacific Journal of Clinical Oncology 14 (1): 40-51. PMID 28840962. doi:10.1111/ajco.12756. 
  • Farago AF, Yeap BY, Stanzione M, Hung YP, Heist RS, Marcoux JP, Zhong J, Rangachari D, Barbie DA, Phat S, Myers DT, Morris R, Kem M, Dubash TD, Kennedy EA, Digumarthy SR, Sequist LV, Hata AN, Maheswaran S, Haber DA, Lawrence MS, Shaw AT, Mino-Kenudson M, Dyson NJ, Drapkin BJ (October 2019). «Combination Olaparib and Temozolomide in Relapsed Small-Cell Lung Cancer». Cancer Discov 9 (10): 1372-1387. PMC 7319046. PMID 31416802. doi:10.1158/2159-8290.CD-19-0582. 
  • «Chimiothérapie à gonadotoxicité inconnue et préservation de la fertilité: Exemple du témozolomide» [Unknown gonadotoxicity chemotherapy and preservation of fertility: example of Temozolomide]. Gynécologie, Obstétrique & Fertilité (en francés) 38 (11): 660-2. November 2010. PMID 21030284. doi:10.1016/j.gyobfe.2010.09.002.  Parámetro desconocido |vauthors= ignorado (ayuda)
  • Jacinto FV, Esteller M (August 2007). «MGMT hypermethylation: a prognostic foe, a predictive friend». DNA Repair 6 (8): 1155-60. PMID 17482895. doi:10.1016/j.dnarep.2007.03.013. 
  • Hegi ME, Diserens AC, Gorlia T, Hamou MF, de Tribolet N, Weller M, Kros JM, Hainfellner JA, Mason W, Mariani L, Bromberg JE, Hau P, Mirimanoff RO, Cairncross JG, Janzer RC, Stupp R (March 2005). «MGMT gene silencing and benefit from temozolomide in glioblastoma». The New England Journal of Medicine 352 (10): 997-1003. PMID 15758010. doi:10.1056/NEJMoa043331. 
  • Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, Ludwin SK, Allgeier A, Fisher B, Belanger K, Hau P, Brandes AA, Gijtenbeek J, Marosi C, Vecht CJ, Mokhtari K, Wesseling P, Villa S, Eisenhauer E, Gorlia T, Weller M, Lacombe D, Cairncross JG, Mirimanoff RO, ((European Organisation for Research Treatment of Cancer Brain Tumour Radiation Oncology Groups)), ((National Cancer Institute of Canada Clinical Trials Group))) (May 2009). «Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial». The Lancet. Oncology 10 (5): 459-66. PMID 19269895. doi:10.1016/S1470-2045(09)70025-7. 
  • Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, Ludwin SK, Allgeier A, Fisher B, Belanger K, Hau P, Brandes AA, Gijtenbeek J, Marosi C, Vecht CJ, Mokhtari K, Wesseling P, Villa S, Eisenhauer E, Gorlia T, Weller M, Lacombe D, Cairncross JG, Mirimanoff RO, ((European Organisation for Research Treatment of Cancer Brain Tumour Radiation Oncology Groups)), ((National Cancer Institute of Canada Clinical Trials Group))) (May 2009). «Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial». The Lancet. Oncology 10 (5): 459-66. PMID 19269895. doi:10.1016/S1470-2045(09)70025-7. 

dailymed.nlm.nih.gov

sciencemag.org

blogs.sciencemag.org

semanticscholar.org

api.semanticscholar.org

  • Sperry, Jeffrey B.; Stone, Shane; Azuma, Michael; Barrett, Connor (2021). «Importance of Thermal Stability Data to Avoid Dangerous Reagents: Temozolomide Case Study». Organic Process Research & Development 25 (7): 1690-1700. S2CID 237644612. doi:10.1021/acs.oprd.1c00206. 

unil.ch

serval.unil.ch